Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.82173 | 35 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.81151 | 36 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.8153 | 36 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.7831 | 37 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.77608 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.84726 | 34 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.8372 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.79576 | 35 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.79222 | 36 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.80994 | 36 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.79472 | 35 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.7949 | 36 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.80624 | 35 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.80537 | 36 |